Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelets, platelet-derived growth factor and arteriosclerosis.

H R Baumgartner1, M Hosang

  • 1F. Hoffmann-La Roche & Co. Ltd, Pharmaceutical Research Department, Basel, Switzerland.

Experientia
|February 15, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Repetitive spinal motor neuron discharges following single transcranial magnetic stimulation: relation to dexterity.

Experimental brain research·2008
Same author

Recollections of the development of flow devices for studying mechanisms of hemostasis and thrombosis in flowing whole blood.

Journal of thrombosis and haemostasis : JTH·2004
Same author

A review of neuromuscular blockade in the critically ill patient.

Dynamics (Pembroke, Ont.)·2002
Same author

Specific accumulation of circulating monocytes and polymorphonuclear leukocytes on platelet thrombi in a vascular injury model.

Blood·1997
Same author

Effects of napsagatran (Ro 46-6240), a new synthetic thrombin inhibitor and of heparin in a canine model of coronary artery thrombosis: comparison with an ex vivo annular perfusion chamber model.

The Journal of pharmacology and experimental therapeutics·1996
Same author

Role of collagen-adherent platelets in mediating fibrin formation in flowing whole blood.

Blood·1995

Platelets contribute to arteriosclerosis by forming thrombi and releasing platelet-derived growth factor (PDGF). This growth factor drives smooth muscle cell changes and vasoconstriction, increasing interest in antagonists for treating vascular diseases.

Area of Science:

  • Cardiovascular Biology
  • Hematology
  • Cellular Biology

Background:

  • Platelets are key players in arteriosclerosis pathogenesis and progression.
  • Platelet adhesion to damaged arteries forms mural thrombi, impacting vessel wall integrity.
  • Platelet activation and subsequent thrombus formation are shear rate-dependent, crucial in stenosed arteries and microvasculature.

Purpose of the Study:

  • To elucidate the role of platelets in arteriosclerosis.
  • To investigate the function of platelet-derived growth factor (PDGF) in vascular remodeling and vasoconstriction.
  • To highlight the significance of PDGF in tumorigenesis and the need for antagonists.

Main Methods:

  • Rheologic considerations and blood perfusion experiments using flow chambers.

Related Experiment Videos

  • Analysis of platelet adhesion and thrombus formation under varying wall shear rates.
  • Review of studies on PDGF production by various cells and its implications.

    • Main Results:

    • Platelet participation in thrombosis increases with wall shear rate, particularly in stenosed arteries and microvasculature.
    • Activated platelets release PDGF, a potent mediator of smooth muscle cell migration, proliferation, and vasoconstriction.
    • PDGF is also produced by endothelial cells, macrophages, and smooth muscle cells, suggesting broader roles.

    Conclusions:

    • Platelets are critical in the pathogenesis and progression of arteriosclerosis through thrombosis and PDGF release.
    • PDGF is a central mediator of vascular smooth muscle cell responses and vasoconstriction.
    • The expanded understanding of PDGF's role in arteriosclerosis and tumorigenesis necessitates further research into potential antagonists.